Disease | hematopoietic stem cell transplantation |
Phenotype | C0026986|myelodysplastic syndrome |
Sentences | 4 |
PubMedID- 26147089 | Allogeneic hematopoietic stem cell transplantation in adults with myelodysplastic syndrome: experience of the argentinean group of bone marrow transplantation (gatmo). |
PubMedID- 26497198 | Background: this report focuses on the adaptive phase i trial design aimed to find the clinically applicable dose for decitabine maintenance treatment after allogeneic hematopoietic stem cell transplantation in patients with higher-risk myelodysplastic syndrome and secondary acute myeloid leukemia. |
PubMedID- 23113470 | Response to pretransplant hypomethylating agents influences the outcome of allogeneic hematopoietic stem cell transplantation in adults with myelodysplastic syndromes. |
PubMedID- 25778887 | Objective: to evaluate the efficacy of decitabine (dac) bridging therapy followed by allogeneic hematopoietic stem cell transplantation (allo-hsct) in patients with myelodysplastic syndrome (mds). |
Page: 1